Bunai T, et al. - The clinicians performed this study to examine the progression of neuroinflammation following disease modifying therapy (DMT) in multiple sclerosis (MS). They demonstrated that even after receiving DMT, microglial activation could proceed in the entire brain of clinically stable MS patients.